Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 2 , Pages 324-333 , April 2010

Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery

  • Himanshu Gupta, B.Pharm, M.Pharm

      Affiliations

    • Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India
    • Department of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, Ministry of Defence, New Delhi, India
    • H. Gupta was the recipient of a Senior Research Fellowship from the Council of Scientific and Industrial Research (Government of India), New Delhi, India.
    • ,
  • Mohammed Aqil, M.Pharm, PhD

      Affiliations

    • Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India
    • Corresponding Author InformationCorresponding author: Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi 110062, India.
    • ,
  • Roop K. Khar, M.Pharm, PhD

      Affiliations

    • Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India
    • ,
  • Asgar Ali, M.Pharm, PhD

      Affiliations

    • Department of Pharmaceutics, Faculty of Pharmacy, Jamia Hamdard, New Delhi, India
    • ,
  • Aseem Bhatnagar, MBBS, MD

      Affiliations

    • Department of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, Ministry of Defence, New Delhi, India
    • ,
  • Gaurav Mittal, MSc, PhD

      Affiliations

    • Department of Nuclear Medicine, Institute of Nuclear Medicine and Allied Sciences, Ministry of Defence, New Delhi, India

Received 14 June 2009 ,Accepted 8 October 2009.

References 

  1. Zhang W, Prausnitz MR, Edwards A. Modal of transient drug diffusion across cornea. J Controlled Release. 2004;99:241–258
  2. Indu PK, Smitha R. Penetration enhancers and ocular bioadhesive: two new avenues for ophathalmic drug delivery. Drug Devel Ind Pharm. 2002;28:353–369
  3. De Campos AM, Diebold Y, Carvaiho ELS, Sanchez A, Alonso MJ. Chitosan nanoparticles as new ocular drug delivery system: in vitro stability, in vivo fate, and cellular toxicity. Pharm Res. 2004;21:803–810
  4. Ding S. Recent developments in ophthalmic drug delivery. Pharm Sci Technol Today. 1998;1:328–335
  5. Hill JM, O'Callaghan RJ, Hobden JA, Kaufman E. Corneal collagen shields for ocular drug delivery. In:  Mita AK editors. Ophthalmic drug delivery systems. New York: Marcel Dekker; 1993;p. 261–275
  6. Pleyer U, Lutz S, Jusko W, Nguyen K, Narawane M, Rückert D, et al. Ocular absorption of topically applied FK506 from liposomal and oil formulations in rabbit eye. Invest Ophthalmol Vis Sci. 1993;34:2737–2742
  7. Bochot A, Fattal E, Grossiord JL, Puisieux F, Couvereur P. Characterization of a new ocular delivery system based on a dispersion of liposomes in a thermosensitive gel. Int J Pharm. 1998;162:119–127
  8. Losa C, Calvo P, Castro E, Vila-Jato JL, Alonso MJ. Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles. J Pharm Pharmacol. 1991;43:548–552
  9. Losa C, Marchal-Heussler L, Orallo F, Vila-Jato JL, Alonso MJ. Design of new formulations for topical ocular administration: polymeric nanocapsules containing metipranolol. Pharm Res. 1993;10:80–87
  10. De Campos AM, Sánchez A, Gref R, Calvo P, Alonso MJ. The effect of PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa. Eur J Pharm Sci. 2003;20:73–81
  11. Kayser O, Lemke A, Hernandez-Trejo . The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol. 2005;6:3–5
  12. Mainardes RM, Urban MCC, Cinto PO, Khalil NM, Chaud MV, Evangelista RC, et al. Colloidal carriers for ophthalmic drug delivery. Curr Drug Targets. 2005;3:363–371
  13. Guinedi AS, Mortada ND, Mansour S, Hathout RM, et al. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide. Int J Pharm. 2005;306:71–82
  14. Patravale VB, Date Abhijit A, Kulkarni RM. Nanosuspension: a promising drug delivery strategy. J Pharm Pharmacol. 2004;56:827–840
  15. Kreuter J. Nanoparticles. In:  Kreuter J editors. Colloidal drug delivery systems. New York: Marcel Dekker; 1994;p. 219–342
  16. Agnihotri SM, Vavia PR. Diclofenac-loaded biopolymeric nanosuspensions for ophthalmic application. Nanomedicine: NBM. 2009;5:90–95
  17. Vege E, Gamisans F, Garcia ML, Chauvet A, Lancoulonche F, Egea MA. PLGA nanospheres for ocular delivery of flurbiprofen: drug resealse and interactions. J Pharm Sci. 2008;97:5306–5317
  18. Araujo J, Vega E, Lopes C, Egea MA, Garcia ML, Souto EB. Effect of polymer viscosity on physicochemical properties and ocular tolerance of FB-loaded PLGA nanospheres. Colloids Surf B Biointerfaces. 2009;72:48–56
  19. In:  Sweetman S editors. Martindale: the complete drug reference [electronic version]. London: Pharmaceutical Press; 2009;
  20. Kassem MA, Abdel Rahman AA, Ghorab MM, Ahmed MB, Khalil RM. Nanosuspension as an ophthalmic delivery system for certain glucocorticoid drugs. Int J Pharm. 2007;340:126–133
  21. Hui HW, Robinson JR. Effect of particle dissolution rate on ocular drug bioavailability. J Pharm Sci. 1986;75:280–287
  22. Schoenwald RD, Stewart P. Effect of particle size on ophthalmic bioavailability of dexamethasone suspensions in rabbits. J Pharm Sci. 1980;69:391–394
  23. Muthu MS, Rawat MK, Mishra A, Singh S. PLGA nanoparticle formulations of risperidone: preparation and neuropharmacological evaluation. Nanomedicine: NBM. 2009;5(3):323–333
  24. Gupta H, Jain S, Mathur R, Mishra AK, Mishra P, Velpandian T. Sustained ocular drug delivery from a temperature and pH triggered in-situ gel system. Drug Deliv. 2007;14:507–515
  25. Spielmann H. Ocular irritation. In:  Castle JV,  Gomez MJ editor. In vitro methods in pharmaceutical research. San Diego, CA: Academic Press; 1997;p. 265–287
  26. Gupta H, Aqil M, Khar RK, Ali A, Sharma A, Chander P. Development and validation of stability indicating RP-UPLC method for the quantitative analysis of sparfloxacin. J Chromatogr Sci (in press).
  27. Govender T, Stolnik S, Garnett MC, Illum L, Davis S. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Controlled Release. 1999;57:171–185
  28. Ahlin P, Kristl J, Kristl A, Vrecer F. Investigation of polymeric nanoparticles as carriers of enaprilat for oral administration. Int J Pharm. 2002;239:113–120
  29. Pignatello R, Bucolo C, Ferrar P, Maltese A, Puleo A, Puglisi G. Eudragit RS100® nanosuspensions for the ophthalmic controlled delivery of ibuprofen. Eur J Pharm Sci. 2002;16:53–61
  30. Elund U, Albertsson AC. Morphology engineering of a novel PLLAPDXO. J Polym Sci A Polym Chem. 2002;38:793–795
  31. Sultana Y, Aqil M, Ali A. Ion-activated, gelrite-based in situ ophthalmic gels of pefloxacin mesylate : comparison with conventional eye drops. Drug Deliv. 2006;13:215–219
  32. Aukunuru JV, Kompella UB. In vitro delivery of nano- and micro- particles to retinal pigment epithelial (RPE) cells. Drug Del Technol. 2002;2:50–57
  33. Kohane DS, Tse JY, Yeo Y, Padera R, Shubina M, Robert L. Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J Biomed Mater Res Part A. 2006;77A:351–361
  34. Mainardes RM, Evangelista RC. PLGA nanoparticles containing praziquantel: effect of formulation variables on size distribution. Int J Pharm. 2005;290:137–144
  35. Muller RH, Jacob C. Production and characterization of a budenoside nanosuspension for pulmonary administration. Pharm Res. 2002;19:189–194
  36. Betancourt T, Brown B, Brannon-Peppas L. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation. Nanomedicine. 2007;2:219–232
  37. Sinha VR, Trehan A. Biodegradable microspheres for protein delivery. J Controlled Release. 2003;90:261–280
  38. Mogi T, Ohtake N, Yoshida M, Chimura R, Kamaga Y, Ando S, et al. Sustained release of 17b-estradiol from poly(lactide-co-glycolide) microspheres in vitro and in vivo. Colloids Surf B Biointerfaces. 2000;17:153–165
  39. Makino K, Mogi T, Ohtake N, Yoshida M, Ando S, Nakajima T, et al. Pulsatile drug release from poly(lactide-co-glycolide) microspheres: how does composition of the polymer matrix affect the time interval between the initial burst and the pulsatile release of drugs?. Colloids Surf B Biointerfaces. 2000;19:173–179
  40. Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly(lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Controlled Release. 2002;82:105–114
  41. Qaddoumi MG, Gukasyan HJ, Davda J, Labhasetwar V, Kim KJ, Lee HLV. Clathrin and caveolin-1 expression in primary pigmented rabbit conjunctival epithelial cells: role in PLGA nanoparticle endocytosis. Mol Vision. 2003;9:559–568
  42. Calvo P, Thomas C, Alonso MJ, Vila Jato JL, Robinson J. Study of the mechanisms of interaction of poly-E-caprolactone nanocapsules with the cornea by confocal laser scanning microscopy. Int J Pharm. 1994;103:283–291

 No conflict of interest was reported by the authors of this article.

PII: S1549-9634(09)00192-0

doi: 10.1016/j.nano.2009.10.004

Nanomedicine: Nanotechnology, Biology and Medicine
Volume 6, Issue 2 , Pages 324-333 , April 2010

Article Tools

* Image Usage & Resolution